financetom
Business
financetom
/
Business
/
What's Going On With Zoom Stock Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Zoom Stock Tuesday?
Nov 25, 2025 8:40 AM

Zoom Communications, Inc. ( ZM ) shares are trading higher Tuesday after the company beat third-quarter estimates and raised its fiscal 2026 guidance.

ZM is delivering impressive returns. See what is driving the movement here.

What To Know: Zoom reported adjusted earnings per share of $1.52, beating the consensus estimate of $1.44. In addition, the company reported revenue of $1.23 billion, beating the consensus estimate of $1.21 billion.

Zoom reported a GAAP operating margin of 25.2% and a non-GAAP operating margin of 41.2%. The company said operating cash flow rose 30.2% year over year, and free cash flow also increased compared to the same quarter last year.

Enterprise revenue grew 6.1% year-over-year, and the number of customers contributing more than $100,000 in trailing 12-month revenue increased 9.2%. Online average monthly churn was 2.7%, flat on a year-over-year basis.

Management highlighted adoption of AI Companion 3.0, Custom AI Companion and its AI-first Customer Experience suite, calling it one of Zoom's strongest CX quarters with broad AI adoption across major deals.

Zoom repurchased approximately 5.1 million shares during the quarter and increased its total common stock repurchase authorization by $1 billion.

Q4 Outlook: The company sees adjusted earnings per share between $1.48 and $1.49, versus the consensus estimate of $1.45. Furthermore, the company sees revenue of $1.230 billion to $1.235 billion, versus the consensus estimate of $1.22 billion.

FY26 Outlook: Zoom raised its adjusted earnings per share guidance from between $5.81 to $5.84 to between $5.95 and $5.97, versus the consensus estimate of $5.88. It also raised its revenue guidance from between $4.82 billion and $4.83 billion to between $4.852 billion and $4.857 billion, versus the consensus estimate of $4.83 billion.

Analyst Changes: Following Zoom’s earnings report, multiple analysts weighed in on the stock.

Cantor Fitzgerald analyst Thomas Blakey reiterated a Neutral rating on Zoom and maintained a $87 price target.

Wedbush analyst Daniel Ives reiterated an Outperform rating on Zoom and maintained a $95 price target.

Needham analyst Joshua Reilly reiterated a Buy rating on Zoom and maintained a $100 price target.

Rosenblatt analyst Catharine Trebnick maintained a Buy rating on Zoom and maintained a $115 price target.

See Also: Abercrombie & Fitch, Titan Machinery, Zoom Communications ( ZM ), Woodward And Other Big Stocks Moving Higher On Tuesday

ZM Price Action: At the time of writing, Zoom shares are trading 12.79% higher at $88.62, according to data from Benzinga Pro.

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
Jan 15 (Reuters) - Gilead Sciences ( GILD ) and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said...
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said in a statement that the...
Automotive Properties REIT Declares January 2025 Distribution
Automotive Properties REIT Declares January 2025 Distribution
Jan 15, 2025
03:49 PM EST, 01/15/2025 (MT Newswires) -- Automotive Properties REIT (APR-UN.TO) Wednesday declared a distribution of $0.067 per REIT unit for the month of January, representing $0.804 per REIT unit on an annualized basis. This is consistent with December's cash distribution. Payment will be made on Feb. 18 to unitholders of record on Jan. 31. Price: 10.66, Change: +0.08, Percent...
Senators demand US trade chief Tai halt late talks on investor protections
Senators demand US trade chief Tai halt late talks on investor protections
Jan 15, 2025
WASHINGTON (Reuters) - A bipartisan group of U.S. senators on Wednesday called on U.S. Trade Representative Katherine Tai to stop secret negotiations with Mexico, Canada and Colombia that would weaken investor protections in some U.S. free trade deals during the Biden administration's final days. The letter, led by Senate Finance Committee Chairman Mike Crapo, a Republican, and the panel's top...
Copyright 2023-2025 - www.financetom.com All Rights Reserved